CTRI Number |
CTRI/2021/08/036066 [Registered on: 31/08/2021] Trial Registered Prospectively |
Last Modified On: |
19/02/2022 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda |
Study Design |
Randomized, Crossover Trial |
Public Title of Study
|
Clinical trial on knee pain |
Scientific Title of Study
|
A randomized, double blind, placebo controlled, cross over study to evaluate the safety and efficacy of a herbal capsule in patients with recent onset of mild to moderate joint knee pain |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
RRS/CL/PL/JH/2021 Version no 1.0 Dated 26 March 2021 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Ashok Godavarthi |
Designation |
C E O |
Affiliation |
Radiant Research Services Pvt. Ltd |
Address |
RADIANT RESEARCH SERVICES PVT. LTD. Plot No:99 A, 8th
Main Road, III Phase, Peenya Industrial Area, Bengaluru, 560058
Karnataka, India.
Bangalore KARNATAKA 560058 India |
Phone |
9880999297 |
Fax |
|
Email |
ashok@radiantresearch.in |
|
Details of Contact Person Scientific Query
|
Name |
Dr Ashok Godavarthi |
Designation |
C E O |
Affiliation |
Radiant Research Services Pvt. Ltd |
Address |
RADIANT RESEARCH SERVICES PVT. LTD. Plot No:99 A, 8th
Main Road, III Phase, Peenya Industrial Area, Bengaluru, 560058
Karnataka, India.
KARNATAKA 560058 India |
Phone |
9880999297 |
Fax |
|
Email |
ashok@radiantresearch.in |
|
Details of Contact Person Public Query
|
Name |
DrSasi Kumar Kuttappan |
Designation |
Chief Scientific Officer |
Affiliation |
Plant Lipids Private Limited |
Address |
Plant Lipids Private Limited
Kolenchery,
Cochin Kerala
India
Ernakulam KERALA 682311 India |
Phone |
9586467677 |
Fax |
|
Email |
sasikumar.kuttappan@plantlipids.com |
|
Source of Monetary or Material Support
|
Plant Lipids Private Limited Kolenchery, Cochin – 682 311, Kerala, India |
|
Primary Sponsor
|
Name |
Plant Lipids Private Limited |
Address |
Kolenchery, Cochin – 682 311, Kerala, India |
Type of Sponsor |
Other [Herbal and Nutraceutical company ] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DrPrakashappa T H |
Sri Venkateshwara Hospitals |
second floor Room number 2 27, 29th Main Road,
Rashtra Kuvempu Nagara, BTM 2nd stage, BTM layout,
PIN-560076,Bangalore KARNATAKA
Bangalore KARNATAKA |
9148103232
svhethics@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Sri Venkateshwara Hospitals Ethics commitee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:M235||Chronic instability of knee. Ayurveda Condition: Sandhishula, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Other than Classical | | (1) Medicine Name: Herbal (contains Black Pepper oil, Turmeric extract, Sunflower Lecithin, Modified Food starch)., Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 250(mg), Frequency: od, Bhaishajya Kal: Sabhakta, Duration: 1 Weeks, anupAna/sahapAna: Yes(details: ), Additional Information: (2) Medicine Name: Herbal (contains Black Pepper oil, Turmeric extract, Sunflower Lecithin, Modified Food starch)., Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 250(mg), Frequency: od, Bhaishajya Kal: Sabhakta, Duration: 1 Weeks, anupAna/sahapAna: Yes(details: ), Additional Information: | 2 | Comparator Arm | Drug | Other than Classical | | (1) Medicine Name: Placebo (Starch), Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 250(mg), Frequency: od, Bhaishajya Kal: Sabhakta, Duration: 1 Weeks, anupAna/sahapAna: Yes(details: ), Additional Information: (2) Medicine Name: Placebo (Starch), Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 250(mg), Frequency: od, Bhaishajya Kal: Sabhakta, Duration: 1 Weeks, anupAna/sahapAna: Yes(details: ), Additional Information: |
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
55.00 Year(s) |
Gender |
Both |
Details |
1) Volunteer aged between 18-55 years (both inclusive)
2) Knee joint pain since 1 month
3) Willingness to follow the protocol requirement as evidenced by written, informed consent.
4) Willingness to complete study questionnaires.
5) Agree not to use any medication (prescription and over the counter), including vitamins and minerals, during the course of this study.
6) Subjects whose blood chemistries are within a normal range or not considered clinically significant if outside the normal range.
|
|
ExclusionCriteria |
Details |
1) Any clinically significant medical history, medical finding or an ongoing medical or psychiatric condition exists which in the opinion of the Investigator could jeopardize the safety of the subject, impact validity of the study results or interfere with the completion of study according to the protocol
2) Significant abnormal findings as determined by baseline history, physical examination, vital signs (blood pressure, pulse rate, respiration rate) hematology, serum chemistry.
3) Diabetes mellitus and other auto-immune disorders like Rheumatoid Arthritis
4) Use of drugs that interfere with gastrointestinal motility and cardiac diseases
5) History of hypersensitivity reactions
6) History or presence of significant alcoholism or drug abuse in the past one year.
7) Participation in a clinical study during the preceding 90 days.
8) Previous abdominal surgery (except appendectomy)
9) Any contraindication to blood sampling.
10) Blood or blood products donated in past 30 days prior to study supplement administration.
11) Female subjects on pregnancy and lactating women
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Case Record Numbers |
Blinding/Masking
|
Participant, Investigator and Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
i. Decrease in elevated baseline inflammatory and pain markers.
ii. Decrease in elevated baseline anxiety markers.
iii. Decrease in the pain and stress symptoms evaluated through questionnaire
|
Day-7,Day 0 and Day 8 |
|
Secondary Outcome
|
Outcome |
TimePoints |
To assess the efficacy of herbal capsule in both stress/anxiety parameters |
Day 0 and Day 8 |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" |
Phase of Trial
|
Phase 3/ Phase 4 |
Date of First Enrollment (India)
|
01/09/2021 |
Date of Study Completion (India) |
16/09/2021 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Curcumin is the active
chemical in turmeric root; it blocks inflammatory cytokines and enzymes in two
inflammatory pathways. Several human trials have shown an anti-inflammatory
benefit, which can translate to reduced joint pain and swelling. The yellow
spice is popular in curries and other Indian dishes. Black pepper contains the
bioactive compound piperine, which is an alkaloid like capsaicin, the active
component found in chili powder and cayenne pepper. Piperine has been shown to
help relieve nausea, headaches and poor digestion and also has
anti-inflammatory properties. Still, its most significant benefit may be its
ability to boost the absorption of curcumin. Research supports that combining
the piperine in black pepper with the curcumin in turmeric enhances curcumin
absorption by up to 2,000%. Nuts and seeds are a great dietary source of
vitamin E and oils derived from sunflower seeds are rich in vitamin E. Evidence
suggests that increasing the intake of vitamin K sources such as kale, spinach,
broccoli and Brussels sprouts may also benefit people with osteoarthritis. |